Clinical trial
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
NCT03007394 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 19, 2017
- Completion date
- December 1, 2019
- Enrollment
- 272 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.